ACADM, an acyl-CoA dehydrogenase, catalyzes mitochondrial fatty acid beta-oxidation and is differentially expressed in hepatocellular carcinoma [29], cholangiocarcinoma [30], and coronary microvascular dysfunction [31]. The gene discussed is ACADM; the disease is cholangiocarcinoma.